![Jian Sun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jian Sun
Corporate Officer/Principal bei Lianyuangang Chia Tai Tianqing Medicine Co., Ltd.
Aktive Positionen von Jian Sun
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. | Corporate Officer/Principal | 19.08.2011 | - |
Karriereverlauf von Jian Sun
Ehemalige bekannte Positionen von Jian Sun
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
![]() Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Präsident | 19.08.2011 | - |
Statistik
International
China | 3 |
Operativ
President | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
![]() Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Lianyuangang Chia Tai Tianqing Medicine Co., Ltd. |